Serum levels of soluble HLA and IL-2R molecules in patients with urogenital chlamydia infection

13Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Cellular immunity plays a central role in immune response to chlamydial infection, and soluble forms of immune cell membrane antigens take part in the regulation of immune response. Using an immunoenzymatic method, we determined serum levels of soluble HLA molecules (sHLA-I and sHLA-DR) and soluble CD25 molecules (sCD25) in patients with genital chlamydial infection. Specimens from patients with nonspecific inflammation of the urogenital tract were studied and healthy volunteers served as controls. We revealed that serum levels of sHLA-DR and sCD25 increased 3.5- and 2.3-fold, respectively, during chlamydial infection, while the levels of sHLA-I were not changed. Nonspecific inflammation of the urogenital tract was characterized by a 1.5-fold increase in sHLA-I, a 1.6-fold decrease in sCD25, and no changes of sHLA-DR levels in comparison with healthy volunteers. We concluded that Th1 immune responses might dominate during genital chlamydial infection contrary to the state of nonspecific inflammation of urogenital tract. © 2007 Springer Science+Business Media, LLC.

Cite

CITATION STYLE

APA

Novikov, V. V., Egorova, N. I., Kurnikov, G. Y., Evsegneeva, I. V., Baryshnikov, A. Y., & Karaulov, A. V. (2007). Serum levels of soluble HLA and IL-2R molecules in patients with urogenital chlamydia infection. In Advances in Experimental Medicine and Biology (Vol. 601, pp. 285–289). https://doi.org/10.1007/978-0-387-72005-0_30

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free